Journal article icon

Journal article

The UCEIS and UC-100 score were responsive endoscopic and global indices in a phase 2 trial of ulcerative colitis

Abstract:
Lay Summary: This post hoc analysis of a phase 2 placebo-controlled trial of mirikizumab found that the Ulcerative Colitis Endoscopic Index of Severity and the composite UC-100 score were responsive to changes in endoscopic and global ulcerative colitis disease activity, respectively.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1093/crocol/otag031

Authors

More by this author
Institution:
University of Oxford
Role:
Author


Publisher:
Oxford University Press
Journal:
Crohn's & Colitis 360 More from this journal
Volume:
8
Issue:
2
Pages:
otag031
Article number:
otag031
Publication date:
2026-04-24
Acceptance date:
2026-01-19
DOI:
EISSN:
2631-827X
ISSN:
2631-827X


Language:
English
Keywords:
Source identifiers:
4074844
Deposit date:
2026-05-23
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP